Coconut oil's effect on hair loss in breast cancer patients
Official title: The Effect of Coconut Oil on Alopecia in Women Receiving Doxorubucin-Cycylophosphamide Treatment for Breast Cancer
Run by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · NCT06818370 · Data updated 2026-11-12
This study is testing if coconut oil can help reduce hair loss in women with breast cancer who are receiving chemotherapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | Women only |
| Enrollment | 86 (estimated) |
| Sponsor | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Academic / other |
| Drugs / interventions | chemotherapy, Cyclophosphamide, Doxorubicin |
| Locations | 1 site (Ankara, Yenimahalle) |
| Status | Recruiting |
| Started | February 3, 2025 |
| Main results expected | December 31, 2025 |
| Study ends | January 31, 2026 |
| Registry record updated | February 12, 2025 |
| Trial ID | NCT06818370 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 and older diagnosed with breast cancer who are scheduled to receive the Doxorubicin-Cyclophosphamide chemotherapy regimen.
✕Probably not a fit
Patients who have previously experienced hair loss due to other conditions or have received prior chemotherapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the impact of coconut oil on alopecia in 86 female breast cancer patients undergoing chemotherapy with the Doxorubicin-Cyclophosphamide protocol. Conducted at Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, the study aims to assess whether coconut oil can mitigate hair loss associated with cancer treatments. Participants will be monitored for changes in hair regrowth and overall scalp health, utilizing established scales for alopecia evaluation. The study is set to take place from February 1, 2025, to December 31, 2025.
Why it matters
Potential benefit: If successful, this study could provide a natural and effective method to reduce chemotherapy-induced hair loss in breast cancer patients.
How similar studies have gone: While there is limited literature on the effects of coconut oil for alopecia, this approach is relatively novel and has not been extensively tested in this specific context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • To have been diagnosed with breast cancer. * The chemotherapy treatment plan should be planned as the Doxorubicin-Cyclophosphamide protocol. * Volunteer to participate in the study. * Be 18 years of age or older. * Being a woman. Exclusion Criteria: * • Having any health problem or disability that prevents communication (vision-hearing problems, neurological, psychiatric diseases). * Planning other treatments other than the Doxorubicin-Cyclophosphamide protocol for the treatment of breast cancer. * Not volunteering to participate in the study. * Having previously experienced any disease/skin problem that causes hair loss. * Having received chemotherapy before.
Where it's running
-
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi
Ankara, Yenimahalle, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: İsmail Dakdevir, Nurse
- Email: dakdevirismail@gmail.com
- Phone: +905533228416
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.